Pharma R&D Returns Grow Again, But Deloitte Warns Progress is 'Fragile'

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’